Company / AR per Share
REGENXBIO Inc. AR per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.53
FY2025
5-year range
$0.46 / $0.87
FY2021-FY2025
Trend
+14.5%
vs FY2024
Sector context
#65 of 115
Health Care
What the data says
At $0.53, REGENXBIO Inc.'s ar per share ranks #65 of 115 in the Health Care sector. AR per Share returned to growth in FY2025 after 4 years of decline, reaching $0.53.
Based on SEC 10-K filings.
0.53 in FY2025 with a 5-year CAGR of -14.5%.
Declined from $0.57 to $0.53 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -6.7%
- 5-Year CAGR
- -14.5%
- 10-Year CAGR
- -
Sector benchmark
#65 of 115 in Health CareTop 57% of 115This company $0.53 Sector average $27.05
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 14.5% year-over-year.
- Ranks #65 out of 115 companies in the Health Care sector.
- Peak ar per share was recorded in FY2020.
- Lowest ar per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | +14.5% |
| FY2024 | $0.46 | -18.8% |
| FY2023 | $0.57 | -12.7% |
| FY2022 | $0.66 | -24.3% |
| FY2021 | $0.87 | -25.5% |
| FY2020 | $1.16 | +617.7% |
| FY2019 | $0.16 | -84.0% |
| FY2018 | $1.01 | +357.0% |
| FY2017 | $0.22 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026